< 1 minute read
Oct. 6, 2021

MK-8262: A CETP Inhibitor

MK-8262

potential best-in-class CETP inh. (<1 mg QD) completed Ph. I in HV; discont. as backup from anacetrapib Journal of Medicinal Chemistry Merck & Co., Kenilworth, NJ, USA

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in